Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/Stenting A Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association [EHRA] and the European Association of Percutaneous Cardiovascular Interventions [EAPCI]

Research output: Contribution to journalReview article

Standard

Harvard

APA

Vancouver

Author

Bibtex

@article{f5fce559e4d04c228f4b3c71eba938b1,
title = "Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/Stenting A Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association [EHRA] and the European Association of Percutaneous Cardiovascular Interventions [EAPCI]",
abstract = "There remains uncertainty over optimal antithrombotic management strategy for patients with atrial fibrillation (AF) presenting with an acute coronary syndrome and/or undergoing percutaneous coronary intervention/stenting. Clinicians need to balance the risk of stroke and thromboembolism against the risk of recurrent cardiac ischaemia and/or stent thrombosis, and the risk of bleeding. This consensus document comprehensively reviews the published evidence and presents a consensus statement on a 'best practice' antithrombotic therapy guideline for the management of antithrombotic therapy in such AF patients.",
keywords = "percutaneous coronary intervention, acute coronary syndrome, warfarin, stenting, antithrombotic therapy, Arial fibrillation",
author = "Gregory Lip and K Huber and F Andreotti and H Arnesen and KJ Airaksinen and T Cuisset and Paulus Kirchhof and F Marin",
year = "2010",
month = jan,
day = "1",
doi = "10.1160/TH09-08-0580",
language = "English",
volume = "103",
pages = "13--28",
journal = "Thrombosis and Haemostasis",
issn = "0340-6245",
publisher = "Schattauer",
number = "1",

}

RIS

TY - JOUR

T1 - Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/Stenting A Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association [EHRA] and the European Association of Percutaneous Cardiovascular Interventions [EAPCI]

AU - Lip, Gregory

AU - Huber, K

AU - Andreotti, F

AU - Arnesen, H

AU - Airaksinen, KJ

AU - Cuisset, T

AU - Kirchhof, Paulus

AU - Marin, F

PY - 2010/1/1

Y1 - 2010/1/1

N2 - There remains uncertainty over optimal antithrombotic management strategy for patients with atrial fibrillation (AF) presenting with an acute coronary syndrome and/or undergoing percutaneous coronary intervention/stenting. Clinicians need to balance the risk of stroke and thromboembolism against the risk of recurrent cardiac ischaemia and/or stent thrombosis, and the risk of bleeding. This consensus document comprehensively reviews the published evidence and presents a consensus statement on a 'best practice' antithrombotic therapy guideline for the management of antithrombotic therapy in such AF patients.

AB - There remains uncertainty over optimal antithrombotic management strategy for patients with atrial fibrillation (AF) presenting with an acute coronary syndrome and/or undergoing percutaneous coronary intervention/stenting. Clinicians need to balance the risk of stroke and thromboembolism against the risk of recurrent cardiac ischaemia and/or stent thrombosis, and the risk of bleeding. This consensus document comprehensively reviews the published evidence and presents a consensus statement on a 'best practice' antithrombotic therapy guideline for the management of antithrombotic therapy in such AF patients.

KW - percutaneous coronary intervention

KW - acute coronary syndrome

KW - warfarin

KW - stenting

KW - antithrombotic therapy

KW - Arial fibrillation

U2 - 10.1160/TH09-08-0580

DO - 10.1160/TH09-08-0580

M3 - Review article

C2 - 20062939

VL - 103

SP - 13

EP - 28

JO - Thrombosis and Haemostasis

JF - Thrombosis and Haemostasis

SN - 0340-6245

IS - 1

ER -